Dyslipidemias
Products Related to Dyslipidemias(104)
- GC49389Tritylolmesartan MedoxomilCAS: 144690-92-6Purity: >98.00%
An intermediate in the synthesis of olmesartan medoxomil
- GC49393all-trans-13,14-DihydroretinolCAS: 115797-14-3Purity: >95.50%
A metabolite of all- trans retinoic acid
- GC494273,5-Diiodo-L-thyronineCAS: 1041-01-6Purity: >95.00%
3,5-Diiodo-L-thyronine is an endogenous metabolite.
- GC49486Meglutol-d3CAS: 59060-36-5Purity: >99.00%
An internal standard for the quantification of meglutol
- GC49690(3R,5R)-Rosuvastatin (calcium salt)CAS: 1422515-55-6Purity: >95.00%
A potential impurity found in bulk preparations of rosuvastatin
- GC520566(Z),9(Z),12(Z),15(Z)-Hexadecatetraenoic Acid ethyl esterCAS: 845779-89-7Purity: >98.00%
6(Z),9(Z),12(Z),15(Z)-Hexadecatetraenoic Acid ethyl ester is an orally active n-1PUFA.
- GC5207110-oxo-12(Z)-Octadecenoic AcidCAS: 103521-29-5Purity: >95.00%
A metabolite of linoleic acid and an activator of TRPV1
- GC523243-(3-Hydroxyphenyl)propionic Acid sulfateCAS: 86321-32-6Purity: >95.00%
A metabolite of certain phenols and glycosides
- GC52390Spexin 1 (human, mouse, rat, bovine) (acetate)Purity: >98.00%
An endogenous peptide and agonist of GAL 2 and GAL 3
- GC5242810-oxo-12(Z)-Octadecenoic Acid-d5Purity: >99.00%
An internal standard for the quantification of 10-oxo-12(Z)-octadecenoic acid
- GC52504Human Vitamin D Receptor Reporter Assay SystemPurity: >98%
A nuclear receptor cell-based reporter assay
- GC620333α-Hydroxy pravastatin sodiumCAS: 81093-43-8Purity: >98%
3α-Hydroxy pravastatin sodium is the major metabolite of Pravastatin.
- GC72222SurvodutideCAS: 2805997-46-8Purity: >99.50%
Survodutide (BI 456906) is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively.
- GC90698Eicosapentaenoic Acid-d5 ethyl esterCAS: 2483831-19-0Purity: >99.00%
An internal standard for the quantification of eicosapentaenoic acid ethyl ester
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49389 | Tritylolmesartan Medoxomil | 144690-92-6 | >98.00% | |
An intermediate in the synthesis of olmesartan medoxomil | ||||
| GC49393 | all-trans-13,14-Dihydroretinol | 115797-14-3 | >95.50% | |
A metabolite of all- trans retinoic acid | ||||
| GC49427 | 3,5-Diiodo-L-thyronine | 1041-01-6 | >95.00% | |
3,5-Diiodo-L-thyronine is an endogenous metabolite. | ||||
| GC49486 | Meglutol-d3 | 59060-36-5 | >99.00% | |
An internal standard for the quantification of meglutol | ||||
| GC49671 | 2,3-Oxidosqualene | 7200-26-2 | >90.00% | |
An intermediate in the biosynthesis of sterols | ||||
| GC49690 | (3R,5R)-Rosuvastatin (calcium salt) | 1422515-55-6 | >95.00% | |
A potential impurity found in bulk preparations of rosuvastatin | ||||
| GC49879 | Metformin hydroxy analog 2 | 98026-16-5 | >90.00% | |
An oxidation product of metformin | ||||
| GC49885 | BQ-3020 (trifluoroacetate salt) | - | >90.00% | |
A peptide ET B receptor antagonist | ||||
| GC50196 | Simvastatin - d6 | 1002347-71-8 | >99.50% | |
Deuterated simvastatin | ||||
| GC52047 | Fustin | 20725-03-5 | >98.00% | |
| GC52056 | 6(Z),9(Z),12(Z),15(Z)-Hexadecatetraenoic Acid ethyl ester | 845779-89-7 | >98.00% | |
6(Z),9(Z),12(Z),15(Z)-Hexadecatetraenoic Acid ethyl ester is an orally active n-1PUFA. | ||||
| GC52071 | 10-oxo-12(Z)-Octadecenoic Acid | 103521-29-5 | >95.00% | |
A metabolite of linoleic acid and an activator of TRPV1 | ||||
| GC52125 | T-1095 | 209746-59-8 | >98.00% | |
T-1095 is a selective and orally active Na+-glucose cotransporter (SGLT) inhibitor with IC50s of 22.8 ?M and 2.3 ?M for human SGLT1 and SGLT2, respectively. | ||||
| GC52149 | 306-O12B | 2566523-06-4 | >98.00% | |
306-O12B is an ionizable cationic lipid used to generate lipid nanoparticles (LNPs). | ||||
| GC52324 | 3-(3-Hydroxyphenyl)propionic Acid sulfate | 86321-32-6 | >95.00% | |
A metabolite of certain phenols and glycosides | ||||
| GC52390 | Spexin 1 (human, mouse, rat, bovine) (acetate) | - | >98.00% | |
An endogenous peptide and agonist of GAL 2 and GAL 3 | ||||
| GC52428 | 10-oxo-12(Z)-Octadecenoic Acid-d5 | - | >99.00% | |
An internal standard for the quantification of 10-oxo-12(Z)-octadecenoic acid | ||||
| GC52504 | Human Vitamin D Receptor Reporter Assay System | - | >98% | |
A nuclear receptor cell-based reporter assay | ||||
| GC62033 | 3α-Hydroxy pravastatin sodium | 81093-43-8 | >98% | |
3α-Hydroxy pravastatin sodium is the major metabolite of Pravastatin. | ||||
| GC62711 | BAMEA-O16B | 2490668-30-7 | >99.00% | |
BAMEAO16B is a lipid nanoparticle. | ||||
| GC72222 | Survodutide | 2805997-46-8 | >99.50% | |
Survodutide (BI 456906) is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. | ||||
| GC90583 | Heptafluorobutyric Acid | 375-22-4 | >80.00% | |
A perfluoroalkyl substance | ||||
| GC90697 | Docosahexaenoic Acid-d5 ethyl ester | 159146-01-7 | >99.00% | |
N/A | ||||
| GC90698 | Eicosapentaenoic Acid-d5 ethyl ester | 2483831-19-0 | >99.00% | |
An internal standard for the quantification of eicosapentaenoic acid ethyl ester | ||||